QSAM Biosciences, Inc.·5

Feb 16, 4:01 PM ET

Peitz Tristan 5

5 · QSAM Biosciences, Inc. · Filed Feb 16, 2021

Insider Transaction Report

Form 5
Period: 2020-12-31
Transactions
  • Award

    COMMON STOCK

    2020-12-17$0.22/sh+36,364$8,00036,364 total
  • Award

    Options to Buy Common Stock

    2020-01-06+40,00040,000 total
    Exercise: $0.50From: 2020-01-06Exp: 2030-01-06COMMON STOCK (40,000 underlying)
Holdings
  • Options to Buy Common Stock

    Exercise: $0.50From: 2018-12-01Exp: 2028-06-01COMMON STOCK (32,000 underlying)
    32,000
Footnotes (1)
  • [F1]Shares acquired upon conversion of accrued directors fees at a conversion price of $0.22 per share.

Documents

1 file
  • 5
    ownership.xmlPrimary